Long ‐term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial

ConclusionExtended use of turoctocog alfa is safe and effective for prevention and treatment of bleeding episodes in previously treated patients with haemophilia A across all ages.

https://onlinelibrary.wiley.com/doi/abs/10.1111/hae.13617?af=R

Source: Haemophilia - November 6, 2018 Category: Hematology Authors: Steven R. Lentz, Dragana Janic, Kaan Kavakli, Predrag Miljic, Johannes Oldenburg, Margareth C. Ozelo, Elena Santagostino, Takashi Suzuki, Silva Zupancic Šalek, Lars Korsholm, Irina Matytsina, Andreas Tiede Tags: ORIGINAL ARTICLE Source Type: research